Furthermore, the down-regulation of CXCL12 expression by promoter hypermethylation has been associated with increased metastatic potential in mammary carcinoma cells [22] by the loss of autocrine and paracrine CXCL12 retention at the primary tumor site. Here, CXCL12 is linked to breast carcinoma.